TELA Bio, Inc.

TELA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$37,841-$46,664-$44,296-$33,276
Dep. & Amort.$1,012$808$1,187$535
Deferred Tax-$144$0$0$14
Stock-Based Comp.$4,362$5,032$3,989$3,661
Change in WC-$4,869-$1,669-$5,763-$3,469
Other Non-Cash-$4,115$1,636$4,135$2,103
Operating Cash Flow-$41,595-$40,857-$40,748-$30,432
Investing Activities
PP&E Inv.$0-$611-$872-$627
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4,451$12-$1,000$0
Investing Cash Flow$4,451-$599-$1,872-$627
Financing Activities
Debt Repay.$0$0$10,000$0
Stock Issued$42,919$46,341$34,400$585
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$138-$74-$3,548$0
Financing Cash Flow$43,057$46,267$40,852$585
Forex Effect$28$164-$144$11
Net Chg. in Cash$5,941$4,975-$1,912-$30,463
Supplemental Information
Beg. Cash$46,994$42,019$43,931$74,394
End Cash$52,935$46,994$42,019$43,931
Free Cash Flow-$42,584-$41,468-$42,620-$31,059
TELA Bio, Inc. (TELA) Financial Statements & Key Stats | AlphaPilot